There are various forms of treatment for prostate cancer. In addition to oncologic outcomes,
physicians, and increasingly patients, are focusing on functional and adverse outcomes …

One of the most relevant achievements of Professor Gianni Bonadonna was the
implementation of the methodology of controlled clinical trials in medical oncology. It is valid …

Background and purpose Radiotherapy (RT) induced genitourinary (GU) morbidity is
typically assessed by physicians as single symptoms or aggregated scores including …

Purpose Urinary incontinence (UI) following prostate radiotherapy is a rare toxicity that
adversely affects a patient's quality of life. This study sought to evaluate the incidence of UI …

Background: To present an overview of patient-reported sexual toxicity in sexually active
long-term prostate cancer survivors treated with radiation therapy. Methods: We used patient …

To demonstrate the prevalence and risk factors for overactive bladder symptoms associated
with artificial urinary sphincter implantation, we investigated the patients who underwent …

Aims To quantify and qualify late genitourinary toxicity in a cohort of patients with localised
prostate cancer treated with image-guided intensity-modulated radiotherapy (IMRT) to …

Objective To investigate the rates and predictive factors associated with the development of
de novo overactive bladder (OAB) and to assess the effects of de novo OAB on surgical …

This issue contains a handful of highlight medical physics contributions that were presented
at the 3rd ESTRO Forum held recently in Barcelona. This tradition was established over …

Background. External beam radiotherapy is an excellent treatment for patients with prostate
cancer (PC). Assessing long-term radiotherapy-induced toxicity is important. We evaluated …